Vascular endothelial growth factor (VEGF), which is directly associated with patient prognosis, is an abundantly expressed angiogenic factor in HNSCC (Vassilakopoulou et al. 2015). The gene discussed is VEGFA; the disease is head and neck squamous cell carcinoma.